Mirae Asset Global Investments
DPLO

Mirae Asset Global Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mirae Asset Global Investments’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,346
Closed -$49K – 1530
2019
Q4 		$49K Buy
12,346
+1,174
+11% +$5.51K ﹤0.01% 1464
2019
Q3 		$55K Buy
+11,172
New +$62.5K ﹤0.01% 1417
2017
Q1 		– Sell
-41,736
Closed -$526K – 675
2016
Q4 		$526K Buy
41,736
+12,281
+42% +$229K 0.01% 390
2016
Q3 		$825K Buy
29,455
+758
+3% +$25.4K 0.02% 374
2016
Q2 		$1M Sell
28,697
-2,313
-7% -$72.7K 0.03% 314
2016
Q1 		$850K Buy
31,010
+6,908
+29% +$203K 0.02% 345
2015
Q4 		$825K Buy
+24,102
New +$752K 0.03% 336

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Mirae Asset Global Investments's DPLO Position: Q1 2020 in Review

Mirae Asset Global Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 12,346 shares — an estimated $49K sold.

Mirae Asset Global Investments first reported a position in DPLO in Q4 2015 and held it in 7 quarters. The position peaked at $1M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Mirae Asset Global Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 12,346 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $49K.
  • Mirae Asset Global Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 7 quarters.
  • Mirae Asset Global Investments's DIPLOMAT PHARMACY, INC. position peaked at $1M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Mirae Asset Global Investments's 13F filing for Q1 2020, filed 12 May 2020.